Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

Pharma, Biotech Partner on Off-the-Shelf Cell Therapies

Mitochondria illustration

A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells. . . . → Read More: Pharma, Biotech Partner on Off-the-Shelf Cell Therapies

Moderna Expands Vaccine Research, Mfring in Asia

Syringe and three vials

Moderna Inc. and South Korea signed agreements Saturday on joint research and manufacturing opportunities for vaccines against viruses in Korea. . . . → Read More: Moderna Expands Vaccine Research, Mfring in Asia

Hearing Tech Company Raises New Venture Funds

Smart Ear device and app

A company creating devices that help people with hearing impairments, but without the stigma or cost of hearing aids, is raising $7 million in new venture funds. . . . → Read More: Hearing Tech Company Raises New Venture Funds

Stem Cell Therapy Licensed for Genetic Eye Disease

Red-blue-green eye

A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease

Blood Cancers Respond to Cord Blood Cells

Katy Rezvani

A small-scale clinical trial shows most patients with two blood-related cancers safely respond to immune system cells derived from umbilical cord blood. . . . → Read More: Blood Cancers Respond to Cord Blood Cells

Infographic – China Closes R&D Funding Gap

R&D spending 2017

A new report from National Science Foundation shows China now ranks a close second to the U.S. in total research and development investments. . . . → Read More: Infographic – China Closes R&D Funding Gap

Synthetic Bio Cancer Immunotherapy Company Acquired

Natural killer cell

A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma. . . . → Read More: Synthetic Bio Cancer Immunotherapy Company Acquired

Trial Shows Nanotech Drug Induces Gluten Tolerance

bread and rolls

Results from a clinical trial show an experimental treatment encourages immune-system tolerance of gluten, preventing intestinal damage from celiac disease. . . . → Read More: Trial Shows Nanotech Drug Induces Gluten Tolerance

Migraine Drug Developer Raises $82.5M in IPO

NASDAQ share price display

A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock. . . . → Read More: Migraine Drug Developer Raises $82.5M in IPO

Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Laptops on a table

Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal